Key result
Camellia and herbal teas moderately improve glycemic control, lipids, and BP in T2D.
Meta-Analysis (n=832)
Answers are grounded in this paper and cite their sources.
Evidence for the anti-diabetic actions of camellia and herbal tea in diabetic patients has not been summarized. Several data sources were searched for randomized trials assessing the effect of different teas on cardiometabolic risk factors in T2D subjects. Two independent reviewers extracted relevant data and assessed the risk of bias. Results were summarized using mean differences (MDs) based on a random model. Sixteen studies (19 trials, N = 832) fulfilled the eligibility criteria. Mean differences were measured for body weight, body mass index, fasting blood glucose, glycosylated hemoglobin, a homeostatic model for insulin resistance, high and low-density lipoproteins, triglycerides, and systolic and diastolic blood pressure. No effects on total cholesterol and waist circumference were observed when either camellia or herbal tea was consumed. Tea produced moderate regulatory effects on adipose, glycemic control, lipid profiles, and blood pressure. In terms of efficacy, camellia and herbal teas yield different benefits in regulating metabolism. This discovery has some implications for clinical research and drug development. However, more high-quality trials are needed to improve the certainty of our estimates.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted a meta-analysis in Type 2 diabetes mellitus (n=832). Camellia tea and herbal tea was evaluated on Cardiometabolic risk factors (body weight, BMI, FBG, HbA1c, HOMA-IR, HDL, LDL, triglycerides, SBP, DBP, total cholesterol, waist circumference). Camellia and herbal teas across 19 RCTs (N=832) moderately regulated glycemic control, lipids, and blood pressure in T2D patients without affecting total cholesterol or waist circumference.
Synapse has enriched 10 related papers. Consider them for comparative context: